Jordánia - angol - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

الشركة العربية لصناعة الادوية المساهمة الخاصة - the arab pharmaceutical manufacturing psc - alogliptin as benzoate 25 mg - as benzoate 25 mg

Izrael - angol - Ministry of Health

ferring pharmaceuticals ltd - triptorelin as embonate - powder and solvent for suspension for injection - triptorelin as embonate 3.75 mg ml - triptorelin - triptorelin - - lowering of sexual hormones and - treatment of advanced hormone-dependent prostate cancer. - central precocious puberty.- as adjuvant treatment in combination with tamoxifen or an aromatase inhibitor of hormone receptor-positive early stage breast cancer in women at high risk of recurrence and who are confirmed as pre-menopausal after completion of chemotherapy and in men at high risk of recurrence

Izrael - angol - Ministry of Health

inovamed ltd - anastrozole - film coated tablets - anastrozole 1 mg - anastrozole - anastrozole - treatment of advanced breast cancer in post menopausal women. efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.

Izrael - angol - Ministry of Health

rafa laboratories ltd - hyperici herba extractum siccum - film coated tablets - hyperici herba extractum siccum 250 mg - other antidepressants - symptoms of mild to moderate depression including: dejected mood, mood lability, inner restlessness, anxiety, states of tension and the difficulty in falling asleep and sleeping through the night which is associated with these conditions. treatment is recommended for up to 24 weeks.

Izrael - angol - Ministry of Health

novartis israel ltd - lapatinib as ditosylate monohydrate - film coated tablets - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting .• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.

Izrael - angol - Ministry of Health

rafa laboratories ltd - hyperici herba extractum siccum - film coated tablets - hyperici herba extractum siccum 500 mg - other antidepressants - symptoms of mild to moderate depression including: dejected mood, mood lability, inner restlessness, anxiety, states of tension and the difficulty in falling asleep and sleeping through the night which is associated with these conditions.treatment is recommended for up to 24 weeks.

Izrael - angol - Ministry of Health

abic marketing ltd, israel - bosentan as monohydrate - film coated tablets - bosentan as monohydrate 125 mg - bosentan - treatment of pulmonary arterial hypertension (pah) in patients of who functional class ii-iv.reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease.

Izrael - angol - Ministry of Health

abic marketing ltd, israel - bosentan as monohydrate - film coated tablets - bosentan as monohydrate 62.5 mg - bosentan - treatment of pulmonary arterial hypertension (pah) in patients of who functional class ii-iv.reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease.

Izrael - angol - Ministry of Health

ferring pharmaceuticals ltd - triptorelin as embonate - powder and solvent for suspension for injection - triptorelin as embonate 22.5 mg - triptorelin - symptomatic treatment of advanced hormone-dependent prostate cancer. as an alternative treatment, if orchiectomy or the administration of oestrogens are not indicated or are unacceptable to the patient. treatment of central precocious puberty (cpp) in children 2 years and older with an onset of cpp before 8 years in girls and 10 years in boys.

Izrael - angol - Ministry of Health

bayer israel ltd - drospirenone; ethinylestradiol as betadex clathrate; levomefolate calcium; levomefolate calcium - film coated tablets - levomefolate calcium 0.451 mg; ethinylestradiol as betadex clathrate 0.03 mg; drospirenone 3 mg; levomefolate calcium 0.451 mg - estradiol, combinations - oral contraceptive. in women who choose to use an oral contraceptive as their method of contraception, to raise folate levels for the purpose of reducing the risk of a neural tube defect in a pregnancy conceived while taking the product or shortly after discontinuing the product.